G
Gábor Cserni
Researcher at University of Szeged
Publications - 285
Citations - 6457
Gábor Cserni is an academic researcher from University of Szeged. The author has contributed to research in topics: Breast cancer & Sentinel lymph node. The author has an hindex of 41, co-authored 263 publications receiving 5757 citations. Previous affiliations of Gábor Cserni include University of Western Australia & Albert Szent-Györgyi Medical University.
Papers
More filters
Journal ArticleDOI
Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study
Gábor Cserni,Simonetta Bianchi,Vania Vezzosi,Riccardo Arisio,Rita Bori,Johannes L. Peterse,Anna Sapino,Isabella Castellano,Maria Drijkoningen,Janina Kulka,Vincenzo Eusebi,Maria Pia Foschini,Jean Pierre Bellocq,Cristi Marin,Sten Thorstenson,Isabel Amendoeira,Angelika Reiner-Concin,Thomas Decker,Manuela Lacerda,Paulo Figueiredo,Gábor Fejes +20 more
TL;DR: Sentinel lymph node (SLN) biopsy has become the preferred method for the nodal staging of early breast cancer, but controversy exists regarding its universal use and consequences in small tumors.
Journal ArticleDOI
Solid Papillary Breast Carcinomas Resembling the Tall Cell Variant of Papillary Thyroid Neoplasms: A Unique Invasive Tumor With Indolent Behavior
Maria P. Foschini,Sofia Asioli,Susan Foreid,Gábor Cserni,Ian O. Ellis,Vincenzo Eusebi,Juan Rosai +6 more
TL;DR: In this paper, 13 cases of invasive solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (BPTC) are reported, and all the cases were characterized on histology by papillary, follicular as well as solid structures.
Journal ArticleDOI
Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.
John R. Lozada,Thais Basili,Fresia Pareja,Barbara Alemar,Arnaud Da Cruz Paula,Rodrigo Gularte-Mérida,Dilip Giri,Patricia Querzoli,Gábor Cserni,Emad A. Rakha,Maria Pia Foschini,Jorge S. Reis-Filho,Edi Brogi,Britta Weigelt,Felipe C Geyer +14 more
TL;DR: This work sought to characterise their histology and investigate the frequency of IDH2 and PIK3CA mutations in an independent cohort of BPTCs, as well as in conventional solid papillary carcinomas (SPCs).
Journal ArticleDOI
Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries
TL;DR: The lognormal statistical method to estimate survival was retrospectively validated since the 15-year cause-specific survival rates could be calculated using the standard life-table actuarial method, and actuarial calculation can be performed to confirm (validate) the estimation.
Journal ArticleDOI
Axillary Sentinel Node and Tumour-related Factors Associated with Non-sentinel Node Involvement in Breast Cancer
Gábor Cserni,Tomasz Burzykowski,Vincent Vinh-Hung,Lajos Kocsis,Gábor Boross,Mária Sinkó,Miklós Tarján,Rita Bori,Mária Rajtár,Eliza Tekle,Róbert Maráz,Béla Baltás,Mihály Svébis +12 more
TL;DR: Isolated tumour cells and micrometastases in axillary sentinel nodes carry a low risk of non-sentinel node metastases, especially if there is extracapsular growth and the proportion of involved sentinel node is high.